CTNM – contineum therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
We Think Contineum Therapeutics (NASDAQ:CTNM) Can Afford To Drive Business Growth [Yahoo! Finance]
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Contineum Therapeutics (CTNM) was downgraded by Wall Street Zen from
Contineum Therapeutics (CTNM) had its price target raised by Robert W. Baird from $14.00 to $20.00. They now have an "outperform" rating on the stock.
Form SCHEDULE 13G Contineum Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC
Form 4 Contineum Therapeutics, For: Apr 06 Filed by: Lorrain Daniel S.
Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S.
Form S-8 Contineum Therapeutics,
Form 424B5 Contineum Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.